Avelumab first-line maintenance plus best supportive care vs best supportive care alone for advanced urothelial carcinoma: JAVELIN Bladder 100 subgroup analysis based on duration and cycles of first-line chemotherapy

被引：0

作者：

Powles, Thomas ^{[1
]}

Loriot, Yohann ^{[2
]}

Duran, Miguel A. Climent ^{[3
]}

Sridhar, Srikala ^{[4
]}

Bellmunt, Joaquim ^{[5
]}

Petrylak, Daniel P. ^{[6
]}

Wang, Jing ^{[7
]}

Costa, Nuno ^{[8
]}

Laliberte, Robert ^{[9
]}

di Pietro, Alessandra ^{[10
,11
]}

Grivas, Petros ^{[12
]}

Sternberg, Cora N. ^{[13
]}

机构：

[1] Queen Mary Univ London, Barts Canc Inst, St Bartholomews Hosp, Expt Canc Med Ctr, London, England

[2] Univ Paris Saclay, Gustave Roussy, INSERM, U981, Villejuif, France

[3] Inst Valenciano Oncol, Valencia, Spain

[4] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada

[5] Beth Israel Deaconess Med Ctr, Boston, MA USA

[6] Harvard Med Sch, Boston, MA 02115 USA

[7] Yale Canc Ctr, New Haven, CT USA

[8] Pfizer, Cambridge, MA USA

[9] Pfizer, Porto, Portugal

[10] Pfizer Srl, Milan, Italy

[11] Univ Washington, Seattle, WA USA

[12] Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, Clin Res Div, Washington, DC USA

[13] Weill Cornell Med, Hematol Oncol, Englander Inst Precis Med, New York, NY USA

来源：

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 17卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

245

引用

页码：132 / 133

页数：2

共 50 条

[1] Avelumab first-line maintenance plus best supportive care vs best supportive care alone for advanced urothelial carcinoma: JAVELIN Bladder 100 subgroup analysis based on duration and cycles of first-line chemotherapy
Gurney, Howard
Loriot, Yohann
Powles, Thomas
Duran, Climent Miguel
Sridhar, Srikala
Bellmunt, Joaquim
Petrylak, Daniel
Wang, Jing
Costa, Nuno
Laliberte, Robert
Di Pietro, Alessandra
Grivas, Petros
Sternberg, Cora
[J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 46 - 46
[2] Avelumab first-line maintenance plus best supportive care vs best supportive care alone for advanced urothelial carcinoma not progressed with first-line chemotherapy: prespecified subgroup analyses from JAVELIN Bladder 100
Lumba, Sumit
Grivas, Petros
Park, Se Hoon
Voog, Eric
Caserta, Claudia
Valderrama, Begona P.
Gurney, Howard
Kalofonos, Haralabos
Radulovic, Sinisa
Demey, Wim
Ullen, Andres
Loriot, Yohann
Sridhar, Srikala S.
Tsuchiya, Norihiko
Kopyltsov, Evgeny
Gupta, Shilpa
Huang, Bo
Costa, Nuno
Blake-Haskins, John A.
di Pietro, Alessandra
Powles, Thomas
[J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 42 - 43
[3] Avelumab first-line maintenance plus best supportive care vs best supportive care alone for advanced urothelial carcinoma not progressed with first-line chemotherapy: Prespecified subgroup analyses from JAVELIN Bladder 100
Lumba, Sumit
Grivas, Petros
Park, Se Hoon
Voog, Eric
Caserta, Claudia
Valderrama, Begona P.
Gurney, Howard
Kalofonos, Haralabos
Radulovic, Sinisa
Demey, Wim
Ullen, Anders
Loriot, Yohann
Sridhar, Srikala S.
Tsuchiya, Norihiko
Kopyltsov, Evgeny
Gupta, Shilpa
Huang, Bo
Costa, Nuno
Blake-Haskins, John A.
di Pietro, Alessandra
Powles, Thomas
[J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 126 - 126
[4] Avelumab first-line maintenance plus best supportive care (BSC) vs BSC alone for advanced urothelial carcinoma: JAVELIN Bladder 100 Japanese subgroup analysis
Yoshihiko Tomita
Yoshiaki Yamamoto
Norihiko Tsuchiya
Hiroomi Kanayama
Masatoshi Eto
Hideaki Miyake
Thomas Powles
Mizuki Yoshida
Yuichiro Koide
Yoshiko Umeyama
Alessandra di Pietro
Hirotsugu Uemura
[J]. International Journal of Clinical Oncology, 2022, 27 : 383 - 395
[5] Avelumab first-line maintenance plus best supportive care (BSC) vs BSC alone for advanced urothelial carcinoma: JAVELIN Bladder 100 Japanese subgroup analysis
Tomita, Yoshihiko
Yamamoto, Yoshiaki
Tsuchiya, Norihiko
Kanayama, Hiroomi
Eto, Masatoshi
Miyake, Hideaki
Powles, Thomas
Yoshida, Mizuki
Koide, Yuichiro
Umeyama, Yoshiko
di Pietro, Alessandra
Uemura, Hirotsugu
[J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (02) : 383 - 395
[6] Avelumab first-line maintenance plus best supportive care vs best supportive care alone for advanced urothelial carcinoma: analysis of time to end of next-line therapy in JAVELIN Bladder 100
Grivas, Petros
Park, Se Hoon
Voog, Eric
Kopyltsov, Evgeny
Gurney, Howard
Muniz, Queiroz Borges David
Rolland, Frederic
Als, Anne Birgitte
Valderrama, Begona
Wang, Jing
Costa, Nuno
Laliberte, Robert
di Pietro, Alessandra
Powles, Thomas
Bellmunt, Joaquim
[J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 45 - 45
[7] AVELUMAB FIRST-LINE MAINTENANCE PLUS BEST SUPPORTIVE CARE VS BEST SUPPORTIVE CARE ALONE FOR ADVANCED UROTHELIAL CARCINOMA: ANALYSIS OF TIME TO END OF NEXT-LINE THERAPY IN JAVELIN BLADDER 100
Grivas, Petros
Park, Se Hoon
Voog, Eric
Kopyltsov, Evgeny
Gurney, Howard
Borges Muniz, David Queiroz
Rolland, Frederic
Als, Anne Birgitte
Valderrama, Begona P.
Wang, Jing
Costa, Nuno
Laliberte, Robert J.
di Pietro, Alessandra
Powles, Thomas
Bellmunt, Joaquim
[J]. JOURNAL OF UROLOGY, 2021, 206 : E765 - E765
[8] Avelumab first-line maintenance plus best supportive care (BSC) vs. BSC alone for advanced urothelial carcinoma: JAVELIN Bladder 100 Asian subgroup analysis
Lee, Jae-Lyun
Desai, Chirag
Park, Se Hoon
Tsuchiya, Norihiko
Su, Po-Jung
Chan, Timothy Tim Wai
Gurney, Howard
Gao, Seasea
Wang, Jing
Sandner, Robin
di Pietro, Alessandra
Eto, Masatoshi
[J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (05) : 256.e17 - 256.e25
[9] Patient-reported Outcomes from JAVELIN Bladder 100: Avelumab First-line Maintenance Plus Best Supportive Care Versus Best Supportive Care Alone for Advanced Urothelial Carcinoma
Grivas, Petros
Kopyltsov, Evgeny
Su, Po-Jung
Parnis, Francis X.
Park, Se Hoon
Yamamoto, Yoshiaki
Fong, Peter C.
Tournigand, Christophe
Duran, Miguel A. Climent
Bamias, Aristotelis
Caserta, Claudia
Chang, Jane
Cislo, Paul
di Pietro, Alessandra
Wang, Jing
Powles, Thomas
[J]. EUROPEAN UROLOGY, 2023, 83 (04) : 320 - 328
[10] Avelumab (Ave) first-line (1L) maintenance plus best supportive care (BSC) versus BSC alone for advanced urothelial carcinoma (UC): JAVELIN Bladder 100 subgroup analysis based on duration and cycles of 1L chemotherapy.
Loriot, Yohann
Powles, Thomas
Duran, Climent Miguel Angel
Sridhar, Srikala S.
Bellmunt, Joaquim
Petrylak, Daniel Peter
Wang Jing
Costa, Nuno Matos
Laliberte, Robert J.
Di Pietro, Alessandra
Grivas, Petros
Sternberg, Cora N.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)

← 1 2 3 4 5 →